The effect of the GLP-1 receptor agonist liraglutide on heart rate and heart rate variability in patients with type-2 diabetes: a randomized double-blind placebo-controlled cross over study

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 6 - Electrocardiography / cardioversion / defibrillation Electrocardiography ESC Premium Access ESC Congress 2016

ESC 365 is supported by

ESC 365 is supported by